Role of H11 kinase in cardiac cell growth

H11 激酶在心肌细胞生长中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): H11 kinase is the eukaryotic homologue of ICP10 protein kinase, a Ras-GAP kinase from Herpes Simplex required for virus growth. In normal tissues, H11 kinase expression is restricted to the heart and skeletal muscle. Although its function remains unknown, H11 kinase probably participates in mechanisms of cell growth because its induction in non-muscular cells promotes transformation into cancer cells. Putative interactions include the nuclear casein kinase II (NUCKS II), a stimulator of cell growth, the protein HSP27, a stimulator of cell survival, and the nucleosome assembly protein-1 (NAP-l), a stimulator of cell proliferation. By subtractive hybridization, we unexpectedly found that H11 kinase transcript and protein are upregulated in large mammalian models of reversible ischemia/reperfusion and chronic left ventricular hypertrophy. Our preliminary data show that overexpression of H11 kinase in isolated cardiac myocytes promotes cell growth. A cardiac-specific transgenic mouse has been generated, which confirms that overexpression of H11 kinase induces cardiac hypertrophy and protects against cell death during ischemia/reperfusion in vivo. Based on these observations, the overall goal of this proposal is to determine the physiological role, signaling mechanisms and functional importance of H11 kinase in the myocardium. The first specific aim is to determine in vivo the functional and genomic effects of H11 kinase overexpression in a cardiac-specific transgenic mouse model submitted to transverse aortic banding or ischemia/reperfusion. We hypothesize that H11 kinase overexpression in transgenic mice will decrease irreversible cellular damage in hypertrophied and ischemic hearts. The second aim is to determine the signaling pathways in which H11 kinase is integrated. We hypothesize that H11 kinase promotes cardiac growth and survival by stimulating NUCKS II, HSP27 and NAP-l, but that other unexpected proteins might interact as well. The third aim is to show, both in vitro with a dominant negative and in vivo in a knock-out model, that H11 kinase represents an essential pathway of cardiac growth and survival. We hypothesize that the tissue-restricted expression of H11 kinase underlies a specific signaling pathway that is not dispensable for normal cardiac cell growth. These experiments will unravel novel mechanisms and signaling pathways of cardiac growth, which may result in new therapeutic avenues for both ischemic heart disease and heart failure.
描述(由申请人提供):H11激酶是ICP 10蛋白激酶的真核同源物,ICP 10蛋白激酶是病毒生长所需的来自单纯疱疹的Ras-GAP激酶。在正常组织中,H11激酶表达仅限于心脏和骨骼肌。虽然其功能仍然未知,但H11激酶可能参与细胞生长机制,因为其在非肌细胞中的诱导促进转化为癌细胞。假定的相互作用包括核酪蛋白激酶II(NUCKS II),细胞生长的刺激物,蛋白HSP 27,细胞存活的刺激物,和核小体组装蛋白-1(NAP-1),细胞增殖的刺激物。通过消减杂交,我们意外地发现,H11激酶的转录和蛋白质上调大型哺乳动物模型的可逆性缺血/再灌注和慢性左心室肥厚。我们的初步数据表明,H11激酶在分离的心肌细胞中的过表达促进细胞生长。已经产生了心脏特异性转基因小鼠,这证实了H11激酶的过表达诱导心脏肥大,并在体内缺血/再灌注期间保护细胞免于死亡。基于这些观察结果,本提案的总体目标是确定H11激酶在心肌中的生理作用、信号传导机制和功能重要性。第一个具体的目的是确定H11激酶过表达在心脏特异性转基因小鼠模型提交横向主动脉结扎或缺血/再灌注在体内的功能和基因组的影响。我们假设H11激酶在转基因小鼠中的过度表达将减少肥厚和缺血心脏中不可逆的细胞损伤。第二个目的是确定H11激酶整合的信号通路。我们假设H11激酶通过刺激NUCKS II、HSP 27和NAP-1促进心脏生长和存活,但其他意想不到的蛋白质也可能相互作用。第三个目的是显示,无论是在体外显性阴性和在体内敲除模型,H11激酶代表心脏生长和存活的重要途径。我们假设H11激酶的组织限制性表达是一种特异性信号通路的基础,而这种信号通路对于正常的心肌细胞生长并不重要。这些实验将揭示心脏生长的新机制和信号通路,这可能为缺血性心脏病和心力衰竭开辟新的治疗途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christophe Depre其他文献

Christophe Depre的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christophe Depre', 18)}}的其他基金

Pre-emptive conditioning of the ischemic heart
缺血性心脏的先发性调理
  • 批准号:
    7655047
  • 财政年份:
    2009
  • 资助金额:
    $ 37.49万
  • 项目类别:
Pre-emptive conditioning of the ischemic heart
缺血性心脏的先发性调理
  • 批准号:
    7787538
  • 财政年份:
    2009
  • 资助金额:
    $ 37.49万
  • 项目类别:
CORE--Genomics-Proteomics
核心--基因组学-蛋白质组学
  • 批准号:
    7491170
  • 财政年份:
    2007
  • 资助金额:
    $ 37.49万
  • 项目类别:
CORE--Genomics-Proteomics
核心--基因组学-蛋白质组学
  • 批准号:
    7297801
  • 财政年份:
    2006
  • 资助金额:
    $ 37.49万
  • 项目类别:
Role of H11 kinase in cardiac cell growth
H11 激酶在心肌细胞生长中的作用
  • 批准号:
    7150612
  • 财政年份:
    2003
  • 资助金额:
    $ 37.49万
  • 项目类别:
Role of H11 kinase in cardiac cell growth
H11 激酶在心肌细胞生长中的作用
  • 批准号:
    6979775
  • 财政年份:
    2003
  • 资助金额:
    $ 37.49万
  • 项目类别:
Role of H11 kinase in cardiac cell growth
H11 激酶在心肌细胞生长中的作用
  • 批准号:
    6731689
  • 财政年份:
    2003
  • 资助金额:
    $ 37.49万
  • 项目类别:
CORE--Genomics-Proteomics
核心--基因组学-蛋白质组学
  • 批准号:
    8133518
  • 财政年份:
  • 资助金额:
    $ 37.49万
  • 项目类别:
CORE--Genomics-Proteomics
核心--基因组学-蛋白质组学
  • 批准号:
    7673356
  • 财政年份:
  • 资助金额:
    $ 37.49万
  • 项目类别:
CORE--Genomics-Proteomics
核心--基因组学-蛋白质组学
  • 批准号:
    7907577
  • 财政年份:
  • 资助金额:
    $ 37.49万
  • 项目类别:

相似海外基金

Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
  • 批准号:
    10749672
  • 财政年份:
    2024
  • 资助金额:
    $ 37.49万
  • 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
  • 批准号:
    10752276
  • 财政年份:
    2024
  • 资助金额:
    $ 37.49万
  • 项目类别:
Modulators of cardiomyocyte structure to promote functional recovery during cardiac regeneration and repair
心肌细胞结构调节剂促进心脏再生和修复过程中的功能恢复
  • 批准号:
    10751640
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Defining the developmental mechanisms of pericardium formation
定义心包形成的发育机制
  • 批准号:
    10605059
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Label-free single-cell imaging for quality control of cardiomyocyte biomanufacturing
用于心肌细胞生物制造质量控制的无标记单细胞成像
  • 批准号:
    10675976
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Landscapes for Cell State Transition Leveraging by Single-Cell Multi-Omics
单细胞多组学利用细胞状态转变的景观
  • 批准号:
    10712491
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Determining Potential Mechanisms of Worse Outcomes in Black HCM Patients
确定黑人 HCM 患者出现更糟糕结果的潜在机制
  • 批准号:
    10717764
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
  • 批准号:
    10719459
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Mechanisms of outflow tract morphogenesis regulated by extracellular matrix
细胞外基质调控流出道形态发生的机制
  • 批准号:
    10720451
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Regulation of cardiomyocyte proliferation by the Reptin ATPase
Reptin ATP酶对心肌细胞增殖的调节
  • 批准号:
    10747229
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了